# Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy

> **NCT07508046** · — · COMPLETED · sponsor: **West China Hospital** · enrollment: 100 (actual)

## Conditions studied

- Colo-rectal Cancer

## Interventions

- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT07508046
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-11-01
- **Primary completion:** 2026-01-01
- **Final completion:** 2026-01-01
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07508046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07508046, "Clinical Study on the Expression of PHGDH and Its Prognostic Value in Colorectal Cancer Patients Receiving Immunotherapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07508046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*